登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
C10H7OCH2CH(OH)CH2NHCH(CH3)2·HCl
化学文摘社编号:
分子量:
295.80
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
224-096-0
MDL number:
Beilstein/REAXYS Number:
3574966
产品名称
(S)-(-)-普奈洛尔 盐酸盐, ≥98% (TLC), powder
Quality Level
assay
≥98% (TLC)
form
powder
optical activity
[α]25/D −25.5°, c = 1.0 in ethanol(lit.)
mp
193-195 °C (lit.)
solubility
ethanol: 10 mg/mL, DMSO: <14.5 mg/mL, H2O: 50 mg/mL, 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 8.0 mg/mL
originator
AstraZeneca
storage temp.
2-8°C
SMILES string
Cl[H].CC(C)NC[C@H](O)COc1cccc2ccccc12
InChI
1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H/t14-;/m0./s1
InChI key
ZMRUPTIKESYGQW-UQKRIMTDSA-N
Gene Information
human ... ADRB1(153), ADRB2(154), ADRB3(155), HTR1A(3350), HTR1B(3351), HTR1D(3352), HTR1E(3354), HTR1F(3355)
General description
With heat. Aqueous solutions are most stable at pH 3.0 and decompose rapidly at basic pH. Decomposition is accompanied by discoloration of the solution.
Application
(S)-(−)-Propranolol hydrochloride has been used:
- as a non-selective β-blocker propranolol to inhibit the actions of epinephrine in mice
- as a β1- and β2-aadrenergic receptor blocker in rat
- as a medium supplement to investigate its effect on adipogenesis in hemangioma-derived stem cells (HemSC)
Biochem/physiol Actions
(S)-(−)-Propranolol hydrochloride is biologically active enantiomer. It acts as β1 receptor antagonist in thalamocortical neurons. (S)-(−)-Propranolol hydrochloride elicits its inhibitory function on the β1 adrenoceptor in trigeminovascular pain pathway and serves as a preventive medicine in migraine.
Active β-adrenoceptor blocking enantiomer, as measured by inhibition of isoprenaline-induced tachycardia; Propranolol is also non-specific 5-HT1A, 5-HT1B and 5-HT1C serotonin receptor antagonist. The stereoselective association of mianserin and propranolol with the 5HT1A, 5HT1B and 5HT1C sites may prove useful in the characterization of these sites
Features and Benefits
This compound is featured on the β-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
监管及禁止进口产品
此项目有
相关内容
Product Information Sheet
Dietary Tryptophan Restriction Dose-Dependently Modulates Energy Balance, Gut Hormones, and Microbiota in Obesity-Prone Rats
Zapata RC, et al.
Obesity (Silver Spring, Md.), 26(4), 730-739 (2018)
Yee Yin Ho et al.
Food & function, 8(6), 2110-2114 (2017-05-18)
We found that intraduodenal administration of l-ornithine (l-Orn) stimulates growth hormone (GH) secretion in Wistar rats, and then investigated its mechanism. GH-releasing activity after intraduodenal administration of l-Orn was blocked by [d-Lys
Matthew J Shepard et al.
Journal of neurosurgery, 1-9 (2018-12-01)
OBJECTIVEVon Hippel-Lindau disease (VHL) is a tumor predisposition syndrome characterized by CNS hemangioblastomas (HBs) and clear cell renal cell carcinomas (RCCs) due to hypoxia-inducible factor activation (pseudohypoxia). Because of the lack of effective medical therapies for VHL, HBs and RCCs
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| P8688-500MG | 04061834401650 |
| P8688-100MG | 04061834401643 |
